Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.62 |
| ▸ | HPGD | P15428 | 2/20 | 0.61 |
| ▸ | TSHR | P16473 | 1/20 | 0.61 |
| ▸ | RAB9A | P51151 | 2/20 | 0.56 |
| ▸ | MEN1 | O00255 | 3/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.56 |
| ▸ | POLB | P06746 | 3/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.56 |
| ▸ | MAPT | P10636 | 3/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.55 |
| ▸ | PKM | P14618 | 1/20 | 0.54 |
| ▸ | SENP2 | Q9HC62 | 1/20 | 0.54 |
| ▸ | SENP1 | Q9P0U3 | 1/20 | 0.54 |
| ▸ | HTT | P42858 | 1/20 | 0.54 |
| ▸ | RECQL | P46063 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10506317 | 0.87 | SMN1; SMN2 (0.60) | LMNAHPGDTSHRMEN1KMT2A | |
| SCHEMBL8816518 | 0.86 | LMNA (0.58) | LMNAHPGDTSHRMEN1KMT2A | |
| SCHEMBL11196941 | 0.83 | KMT2A (0.59) | LMNAHPGDTSHRRAB9AMEN1 | |
| SCHEMBL2011265 | 0.83 | USP2 (0.58) | LMNAHPGDTSHRRAB9AMEN1 | |
| SCHEMBL15391794 | 0.81 | SMN1; SMN2 (0.70) | LMNAHPGDRAB9AKMT2APOLB | |
| SCHEMBL5523413 | 0.81 | KMT2A (0.57) | LMNAHPGDTSHRRAB9AMEN1 | |
| SCHEMBL13941921 | 0.81 | L3MBTL1 (0.51) | LMNAHPGDTSHRRAB9AMEN1 | |
| SCHEMBL8426765 | 0.81 | HPGD (0.64) | LMNAHPGDTSHRRAB9AMEN1 | |
| SCHEMBL5000233 | 0.80 | LMNA (0.55) | LMNATSHRRAB9AMEN1KMT2A | |
| SCHEMBL6243487 | 0.80 | GAA (0.57) | LMNAHPGDTSHRRAB9AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104513186-B | A kind of preparation method of optically pure dextrorotation Cloprostenol Sodium | 宁波第二激素厂 | 2016-10-05 | — | — | CN | claimed |
| CN-104513186-A | Preparation method of optically pure dextro cloprostenol sodium | Ningbo second hormone factory | 2015-04-15 | — | — | CN | claimed |
| WO-2024128359-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF BONE DISEASES | 전남대학교산학협력단 | 2024-06-20 | — | — | WO | disclosed |
| WO-2024128359-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF BONE DISEASES | 전남대학교산학협력단 | 2024-06-20 | — | — | WO | disclosed |
| CN-108947816-A | A kind of preparation method of chloro phenoxy acetic acid ester | 山东润博生物科技有限公司 | 2018-12-07 | — | — | CN | disclosed |
| CN-104513186-B | A kind of preparation method of optically pure dextrorotation Cloprostenol Sodium | 宁波第二激素厂 | 2016-10-05 | — | — | CN | disclosed |
| CN-104513186-A | Preparation method of optically pure dextro cloprostenol sodium | Ningbo second hormone factory | 2015-04-15 | — | — | CN | disclosed |
| CN-103282346-B | Process for preparation of phenyl carbamate derivatives | BIO PHARM SOLUTIONS CO LTD | 2014-11-19 | — | — | CN | disclosed |
| CN-101432278-B | Diketo-piperazine and piperidine derivatives as antiviral agents | BRISTOL MYERS SQUIBB CO | 2012-11-28 | — | — | CN | disclosed |
| CN-101432278-A | Diketo-piperazine and piperidine derivatives as antiviral agents | BRISTOL MYERS SQUIBB CO (US) | 2009-05-13 | — | — | CN | disclosed |
| US-7449581-B2 | 6-Substituted pyrido-pyrimidines | POCHE PALO ALTO LLC (US) | 2008-11-11 | — | — | US | disclosed |
| EP-1611105-A1 | ISOQUINOLINE-5-SULFONIC ACID AMIDES AS INHIBITORS OF AKT (PROTEIN KINASE B) | ELI LILLY AND COMPANY (US) | 2006-01-04 | — | — | EP | disclosed |
| CN-1678321-A | Methods of treating or preventing autoimmune diseases with 2, 4-pyrimidinediamine compounds | RIGEL PHARMACEUTICALS INC (US) | 2005-10-05 | — | — | CN | disclosed |
| EP-1361880-B1 | 6-SUBSTITUTED PYRIDO-PYRIMIDINES | HOFFMANN LA ROCHE (CH) | 2005-09-28 | — | — | EP | disclosed |
| WO-2004094386-A1 | ISOQUINOLINE-5-SULFONIC ACID AMIDES AS INHIBITORS OF AKT (PROTEIN KINASE B) | ELI LILLY AND COMPANY (US) | 2004-11-04 | — | — | WO | disclosed |
| US-20040116698-A1 | 6-Substituted pyrido-pyrimidines | CHEN JIAN JEFFREY (US) | 2004-06-17 | — | — | US | disclosed |
| US-6696566-B2 | SELECTIVE P38 KINASE INHIBITORS RELATIVE TO CYCLIN-DEPENDENT KINASES AND TYROSINE KINASES | SYNTEX (U.S.A.) LLC | 2004-02-24 | — | — | US | disclosed |
| EP-1361880-A2 | 6-SUBSTITUTED PYRIDO-PYRIMIDINES | F. HOFFMANN-LA ROCHE AG (CH) | 2003-11-19 | — | — | EP | disclosed |
| US-20030171584-A1 | Treating p38 mediated disorders such as arthritis, Crohns disease, irritable bowel syndrome adult respiratory distress syndrome or chronic obstructive pulmonary disease. | SYNTEX (U.S.A.) LLC | 2003-09-11 | — | — | US | disclosed |
| WO-2002064594-A2 | 6-SUBSTITUTED PYRIDO-PYRIMIDINES | F. HOFFMANN-LA ROCHE AG (CH) | 2002-08-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030171584-A1 | Treating p38 mediated disorders such as arthritis, Crohns disease, irritable bowel syndrome adult respiratory distress syndrome or chronic obstructive pulmonary disease. | ARRB1, MAPK1, MAPK8 | LMNA 4583/4885HPGD 623/4885TSHR 981/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.